Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about ESALY Recent news which mentions ESALY < Previous 1 2 3 4 Next > This Is Massive News for Eli Lilly Investors June 29, 2024 Tickers BIIB ESALY LLY NVO Tags Recent Press Releases Market News NVO From Motley Fool Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why April 24, 2024 Tickers BIIB ESALY NEWS Tags Biotech Movers Stories That Matter From Benzinga European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab March 22, 2024 Tickers BIIB ESALF ESALY NEWS Tags Briefs Biotech Movers From Benzinga Eli Lilly's Donanemab For Alzheimer's Hits FDA Speed Breaker, Biogen Stock Gains On Delayed Decision March 08, 2024 Tickers BIIB ESALY LLY NEWS Tags FDA General Movers From Benzinga Biogen Could Engage In $1B-$2B Deals To Fill Revenue Shortfall Gaps, Analyst Says February 14, 2024 Tickers BIIB ESALY NEWS NVS Tags Biotech Movers Benzinga From Benzinga Why Is Biogen Stock Trading Lower On Tuesday? February 13, 2024 Tickers BIIB ESALY NEWS Tags Health Care Earnings Large Cap From Benzinga Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns January 12, 2024 Tickers BIIB DGX ESALY LH Tags Health Care LLY ESALY From Benzinga Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer December 08, 2023 Tickers ESALF ESALY MRK Tags ESALF Benzinga ESALY From Benzinga Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others November 21, 2023 Tickers ACIU BIIB ESAIY ESALY Tags Benzinga Biotech Briefs From Benzinga Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides November 08, 2023 Tickers BIIB ESALY Tags BIIB why it's moving Market News From Benzinga Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage October 13, 2023 Tickers BIIB ESALF ESALY LLY Tags AI Generated Regulations LLY From Benzinga Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready October 11, 2023 Tickers BIIB DGX ESALY LH Tags Briefs DGX ESALY From Benzinga LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly October 10, 2023 Tickers BIIB ESALF ESALY LLY Tags General Biotech ESALY From Benzinga Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories September 25, 2023 Tickers AA AAPL AMZN BIIB Tags AMZN DLAKY TSN From Benzinga Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi September 25, 2023 Tickers BIIB ESALF ESALY Tags BIIB General Market News From Benzinga Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer September 22, 2023 Tickers ESALF ESALY MRK Tags Large Cap Briefs News From Benzinga Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial August 25, 2023 Tickers ESALF ESALY MRK Tags Market News General MRK From Benzinga Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know. August 01, 2023 Tickers BIIB ESALY RETA Tags ESALY Market News RETA From Motley Fool Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts July 07, 2023 Tickers BIIB ESALF ESALY Tags Biotech ESALY Benzinga From Benzinga Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed June 14, 2023 Tickers BIIB ESALY Tags Benzinga Health Care ESALY From Benzinga FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories June 13, 2023 Tickers AAPL ATVI BEP BIIB Tags Top Stories JTKWY MSFT From Benzinga Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources June 13, 2023 Tickers BIIB ESALF ESALY Tags Biotech ESALY Benzinga From Benzinga Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote June 12, 2023 Tickers BIIB ESALF ESALY Tags General FDA Expert Ideas From Benzinga Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low June 12, 2023 Tickers BIIB ESALY ILMN KDNY Tags ORCL SPY Top Stories From Benzinga Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable' June 08, 2023 Tickers BIIB ESALF ESALY Tags ESALY Benzinga Biotech From Benzinga Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories June 08, 2023 Tickers AMZN BLK DIS EADSY Tags BLK Markets NVS From Benzinga FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval June 08, 2023 Tickers BIIB ESALF ESALY Tags General BIIB FDA From Benzinga Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades' June 01, 2023 Tickers ESALY IEF MDT MRK Tags ESALY Benzinga IEF From Benzinga After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer May 26, 2023 Tickers ESALY MRK PFE Tags Biotech Health Care ESALY From Benzinga Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen May 04, 2023 Tickers BIIB ESALF ESALY LLY Tags Expert Ideas ESALY Benzinga From Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.